Rho kinase inhibitors (Ube Industries)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameRho kinase inhibitors (Ube Industries)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionRho-associated kinases inhibitors

TargetsRho-associated kinases

Therapy Area/IndicationsGlaucoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUbe Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesUbe Corp

Active IndicationsN/A

Inactive IndicationsGlaucoma

ATC CodeN/A